METHODS OF DETERMINING PRE OR POST MEAL TIME SLOTS OR INTERVALS IN DIABETES MANAGEMENT
    2.
    发明申请
    METHODS OF DETERMINING PRE OR POST MEAL TIME SLOTS OR INTERVALS IN DIABETES MANAGEMENT 审中-公开
    确定糖尿病管理中预先或后期时间段或间隔的方法

    公开(公告)号:US20090240127A1

    公开(公告)日:2009-09-24

    申请号:US12052639

    申请日:2008-03-20

    Applicant: Pinaki RAY

    Inventor: Pinaki RAY

    CPC classification number: G06F19/3481 A61B5/14532

    Abstract: A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a blood glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing/dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a blood glucose variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.

    Abstract translation: 本文提供了可用于分析和识别大量血糖浓度测量和与患者血糖相关的其它生理参数的模式的糖尿病管理系统或过程。 特别地,监测患者血糖的方法可包括将患者的数据存储在合适的装置上,例如血糖仪。 患者的数据可能包括血糖浓度测量。 糖尿病管理系统或过程可以安装在个人计算机,胰岛素笔,胰岛素泵或葡萄糖计量仪上,但不限于此。 糖尿病管理系统或过程可以从包括测试/给药模式,低血糖模式,高血糖模式,血糖变异性模式和比较模式的数据中识别多种模式类型。 在使用数据管理系统或处理识别特定模式之后,可以在个人计算机或葡萄糖计的屏幕上显示警告消息。 还可以提供其他信息以确保任何规定的糖尿病团队的遵守或指导患者管理患者的糖尿病。

    Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
    3.
    发明授权
    Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway 有权
    物质输送装置和将治疗物质递送至解剖通道的方法

    公开(公告)号:US06494862B1

    公开(公告)日:2002-12-17

    申请号:US09475727

    申请日:1999-12-30

    Abstract: A catheter assembly is provided having a balloon disposed at the distal end thereof. The balloon is capable of being inflated to selectively dilate from a collapsed configuration to an expanded configuration. A syringe assembly is in fluid communication with a delivery lumen of the catheter assembly for allowing a therapeutic substance to be injected into a tissue of a passageway. The syringe assembly includes a portion capable of pivoting from a first position towards a second position when the balloon is being inflated from the collapsed configuration to the expanded configuration. The portion of the syringe assembly is also capable of pivoting from the second position back towards the first position when the balloon is being deflated.

    Abstract translation: 提供具有设置在其远端处的气囊的导管组件。 气囊能够被充气以选择性地从折叠构型扩张到扩张构型。 注射器组件与导管组件的输送腔流体连通,用于允许将治疗物质注射到通道的组织中。 注射器组件包括当气囊从折叠构型膨胀到扩张构型时能够从第一位置向第二位置枢转的部分。 当气囊被放气时,注射器组件的部分还能够从第二位置向后转动到第一位置。

    Methods, Systems, and Devices for Analyzing Patient Data
    8.
    发明申请
    Methods, Systems, and Devices for Analyzing Patient Data 审中-公开
    用于分析患者数据的方法,系统和设备

    公开(公告)号:US20110245634A1

    公开(公告)日:2011-10-06

    申请号:US13078711

    申请日:2011-04-01

    Abstract: Described herein is a method of analyzing an analyte distribution from discrete, quasi-continuous or continuous measurements to determine a glycemic state of a patient in order to understand how often, and for how long, a patient's post-prandial glucose is out of control without requiring laboratory blood test and especially post-prandial levels laboratory analysis. The systems, devices, and methods assist in predicting risk levels of developing diabetes-associated complications. Therefore applicants have recognized also a need for a tool which facilitates stratification of patients for risk of and/or onset of one or more complications having the same HbA1c level.

    Abstract translation: 本文描述的是从离散的,准连续的或连续的测量中分析分析物分布的方法,以确定患者的血糖状态,以便了解患者的餐后葡萄糖的频率以及多长时间,失去控制,没有 需要实验室血液检查,特别是餐后水平的实验室分析。 系统,装置和方法有助于预测发展为糖尿病相关并发症的风险水平。 因此,申请人也认识到需要一种能够使患者具有相同HbA1c水平的一种或多种并发症的风险和/或发作的分层的工具。

    ANALYTE TESTING METHOD AND SYSTEM
    9.
    发明申请
    ANALYTE TESTING METHOD AND SYSTEM 审中-公开
    分析测试方法和系统

    公开(公告)号:US20100332445A1

    公开(公告)日:2010-12-30

    申请号:US12826659

    申请日:2010-06-29

    CPC classification number: G16H15/00 A61B5/14532 A61B5/4839 G16H40/63

    Abstract: A system and method of detecting a flagged glucose concentration pattern with the use of medians having a common type of flag collected over discrete time periods so that whenever significant differences between the medians arise, the user or a caretaker of a diabetic user is notified.

    Abstract translation: 使用具有在离散时间段上收集的共同类型的标志的中值来检测标记的葡萄糖浓度模式的系统和方法,使得只要出现中间值之间的显着差异,就通知糖尿病患者的使用者或看守者。

Patent Agency Ranking